Duffy phenotype does not influence the clinical severity of sickle cell disease

Clinical Immunology

Volumn 96, Issue 3, 2000, Pages 264-268

  Schnog, J B ^a,b   Keli, S O ^a   Pieters, R A ^a,b   Rojer, R A ^a   Duits, A J ^a,b  

^a St Elisabeth Hospital Willemstad   (Netherlands Antilles)

^b Red Cross Bloodbank Curacao   (Netherlands Antilles)

Author keywords

Duffy; Sickle cell disease severity

Indexed keywords

CHEMOKINE; INTERLEUKIN 8; LYMPHOCYTE ANTIGEN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD GROUP DUFFY SYSTEM; BLOOD LEVEL; BLOOD VESSEL OCCLUSION; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHROCYTE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; SICKLE CELL ANEMIA; STEADY STATE;

EID: 0033844367     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2000.4884     Document Type: Article

References (21)

1. From malaria to chemokine receptor: The emerging physiologic role of the Duffy blood group antigen
2. Insights into the structure and function of membrane polypeptides carrying blood group antigens
3. Red blood cells are a sink for interleukin 8, a leukocyte chemotactin
4. Elevated IL-8 levels during sickle cell crisis
5. Erythrocyte adherence to endothelium in sickle cell anemia: A possible determinant of disease severity
6. Red blood cells from patients with sickle cell disease exhibit increased adherence to cultured endothelium pretreated with tumour necrosis factor
7. Screening cord blood for hemoglobinopathies and thalassemia by HPLC
8. New concepts in assessing sickle cell disease severity
9. Pain in sickle cell disease: Rates and risk factors
10. Acute chest syndrome in sickle cell disease: Clinical presentation and course
11. Chemokines: Leukocyte recruitment and activation cytokines
12. The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor
13. Transcytosis and surface presentation of IL-8 by venular endothelial cells
14. Functional and biochemical analysis of the cloned duffy antigen: Identity with the red blood cell chemokine receptor
15. Up-regulation of Duffy antigen receptor expression in children with renal disease
16. Neutrophil activation in sickle cell disease
17. Assessment of painful episode frequency in sickle-cell disease
18. --) phenotype
19. A novel mutation in the coding sequence of the FY*B allele of the Duffy chemokine receptor gene is associated with an altered erythrocyte phenotype
20. Arg89Cys substitution results in very low membrane expression of the Duffy antigen/receptor for chemokines in Fy(x) individuals